[en] The dynamics of colorectal epigenetics within the adenoma stages of oncogenesis remain undocumented. In this study, we investigated DNA methylation dynamics in colorectal cancer oncogenesis from non-tumor colon tissue to low-grade, high-grade adenoma and adenocarcinoma. The methylome of 12 low-grade and 19 high-grade colorectal adenomas was determined via the EPIC v1 Human Methylation BeadChip. These methylation profiles were complemented with the methylomes of 206 non-tumor colon and 22 colon adenocarcinoma samples from the GEO and TCGA databases. Differentially methylated CpGs were identified via Student's t test and used to monitor the evolution of the colon methylome during oncogenesis. The differentially methylated promoters were used to infer the associated biological process via gene ontology and the evolution of the methylation of 34 described colorectal cancer DNA methylation biomarkers was explored. A total of 11.9% of the colon methylome was significantly altered (q < 10- 4) during oncogenesis, with half corresponding to DNA demethylation. Of which, 67.4% occurred during the transition from non-tumor colon tissue to low-grade adenoma. A total of 9% of the DNA methylation changes were specific to low-grade and/or high-grade adenomas. The biological pathways related to the sensory perception of odor and stimulus were hypomethylated early, nucleic acid metabolic process were methylated early, post-transcriptional regulation were transiently hypomethylated and mitotic cell cycle were transiently methylated. Twenty-one out of 34 the biomarkers were methylated in low-grade adenomas and 11 out of 34 in high-grade adenomas. This suggests that they could be used to distinguish stages of oncogenesis. This study provides insight into the dynamics of colonic epigenetics during oncogenesis, with early DNA methylation changes in low-grade adenomas associated with transient DNA methylation changes. However, the causality of these changes remains to be elucidated. This study also explores the evolution of known biomarkers and their clinical applications for indirectly asserting the tumor's stage.
Disciplines :
Oncology
Author, co-author :
Overs, Alexis; Bioinformatique et Big Data Au Service de La Santé, Centre Hospitalier Universitaire de Besançon, 3 Bd Fleming, 25000, Besançon, France. aovers@chu-besancon.fr ; INSERM UMR1098 RIGHT, Université Marie et Louis Pasteur, Besançon, France, 25000. aovers@chu-besancon.fr
Molimard, Chloé; Anatomie et cytologie pathologiques, Centre Hospitalier Universitaire de Besançon, 3 Bd Fleming, 25000, Besançon, France
Durand, Jules ; Université de Liège - ULiège > Département de pharmacie ; INSERM UMR1098 RIGHT, Université Marie et Louis Pasteur, Besançon, France, 25000
Bibeau, Frédéric; Anatomie et cytologie pathologiques, Centre Hospitalier Universitaire de Besançon, 3 Bd Fleming, 25000, Besançon, France
Arnould, Laurent; Anatomie et cytologie pathologiques, Centre Georges François Leclerc, 1 Rue du Professeur Marion, 21000, Dijon, France
Monnien, Franck; Anatomie et cytologie pathologiques, Centre Hospitalier Universitaire de Besançon, 3 Bd Fleming, 25000, Besançon, France
Clavier, Claire; INSERM UMR1098 RIGHT, Université Marie et Louis Pasteur, Besançon, France, 25000
Borg, Christophe; Oncologie médicale, Centre Hospitalier Universitaire de Besançon, 3 Bd Fleming, 25000, Besançon, France
Guittaut, Michael; INSERM UMR1098 RIGHT, Université Marie et Louis Pasteur, Besançon, France, 25000
Feugeas, Jean-Paul; Bioinformatique et Big Data Au Service de La Santé, Centre Hospitalier Universitaire de Besançon, 3 Bd Fleming, 25000, Besançon, France ; INSERM UMR1098 RIGHT, Université Marie et Louis Pasteur, Besançon, France, 25000
Hervouet, Eric; INSERM UMR1098 RIGHT, Université Marie et Louis Pasteur, Besançon, France, 25000
Peixoto, Paul ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > GIGA-R : Labo de recherche sur les métastases ; INSERM UMR1098 RIGHT, Université Marie et Louis Pasteur, Besançon, France, 25000
Selmani, Zohair; INSERM UMR1098 RIGHT, Université Marie et Louis Pasteur, Besançon, France, 25000 ; Oncobiologie, Centre Hospitalier Universitaire de Besançon, 3 Bd Fleming, 25000, Besançon, France
Bray F et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J. Clin. 2024 74 229 263 38572751
Fearon ER Vogelstein B A genetic model for colorectal tumorigenesis Cell 1990 61 759 767 2188735
Nagtegaal ID et al. The 2019 WHO classification of tumours of the digestive system Histopathology 2020 76 182 188 31433515
Hanahan D Hallmarks of cancer: new dimensions Cancer Discov 2022 12 31 46 35022204
Zhu T Tong H Du Z Beck S Teschendorff AE An improved epigenetic counter to track mitotic age in normal and precancerous tissues Nat. Commun. 2024 15 4211 2024NatCo.15.4211Z 38760334 11101651
Galamb O et al. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma World J. Gastroenterol. 2016 22 10325 10340 28058013 5175245
Luebeck GE et al. Implications of epigenetic drift in colorectal neoplasia Cancer Res. 2019 79 495 504 30291105
Murcia O et al. Effects of somatic methylation in colonic polyps on risk of developing metachronous advanced colorectal lesions Cancers (Basel) 2021 13 246 33440809
Kaz AM et al. Patterns of DNA methylation in the normal colon vary by anatomical location, gender, and age Epigenetics 2014 9 492 502 24413027 4121360
Luo Y et al. Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer Gastroenterology 2014 147 418 429e8 24793120
Beggs AD et al. Whole-genome methylation analysis of benign and malignant colorectal tumours J. Pathol. 2013 229 697 704 23096130 3619233
Lu YW et al. Early results of the integrative epigenomic-transcriptomic landscape of colorectal adenoma and cancer World J. Gastrointest. Oncol. 2024 16 414 435 38425399 10900154
Druliner BR et al. Molecular characterization of colorectal adenomas with and without malignancy reveals distinguishing genome, transcriptome and methylome alterations Sci. Rep. 2018 8 3161 2018NatSR..8.3161D 29453410 5816667
Janssens K et al. Epigenome-wide methylation analysis of colorectal carcinoma, adenoma and normal tissue reveals novel biomarkers addressing unmet clinical needs Clin. Epigenetics 2023 15 111 37415235 10327366
Wang T et al. Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk Clin. Epigenetics 2020 12 5 31900199 6942339
Lendvai Á et al. Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia Epigenetics 2012 7 1268 1278 23018867 3499328
R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. (2020). https://www.R-project.org/. https://www.r-project.org/
Wickham H et al. Welcome to the tidyverse J. Open. Source Softw. 2019 4 1686 2019JOSS..4.1686W
Aryee MJ et al. Minfi: a flexible and comprehensive bioconductor package for the analysis of infinium DNA methylation microarrays Bioinformatics 2014 30 1363 1369 24478339 4016708
Phipson B Maksimovic J Oshlack A MissMethyl: an R package for analyzing data from illumina’s HumanMethylation450 platform Bioinformatics 2016 32 286 288 26424855
Ritchie ME et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies Nucleic Acids Res. 2015 43 e47 25605792 4402510
Qin Y et al. An R package for estimating and accounting for tumor purity in cancer methylation research Genes Dis. 2018 5 43 30258934 6147081
Fortin JP et al. Functional normalization of 450k methylation array data improves replication in large cancer studies Genome Biol. 2014 15 503 25599564 4283580
Du P et al. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis BMC Bioinform. 2010 11 587
Lê S Josse J Husson F FactoMineR: an R package for multivariate analysis J. Stat. Softw. 2008 25 1 18
Harris MA et al. The gene ontology (GO) database and informatics resource Nucleic Acids Res. 2004 32 D258 261 2004ees.book...H 14681407
Li B Liu S Gao Y Zheng L Lu Y Combined detection of SDC2/ADHFE1/PPP2R5C methylation in stool DNA for colorectal cancer screening J. Cancer Res. Clin. Oncol. 2023 149 10241 10253 37270460 11797195
Pedersen SK et al. A two-gene blood test for methylated DNA sensitive for colorectal cancer PLoS One 2015 10 e0125041 25928810 4416022
Lima AB et al. Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population Cancer Med. 2023 12 15854 15867 37338022 10469661
Cao Y et al. KCNQ5 and C9orf50 methylation in stool DNA for early detection of colorectal cancer Front. Oncol. 2020 10 621295 33585248
Zhang Y et al. Sensitive detection of colorectal cancer in peripheral blood by a novel methylation assay Clin. Epigenetics 2021 13 90 33892797 8066866
Cao Y et al. Feasibility of methylated CLIP4 in stool for early detection of colorectal cancer: A training study in Chinese population Front. Oncol. 2021 11 647066 33968748 8100593
Lind GE et al. Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas Mol. Cancer 2011 10 85 21777459 3166273
Overs A et al. COL25A1 and METAP1D DNA methylation are promising liquid biopsy epigenetic biomarkers of colorectal cancer using digital PCR Clin. Epigenetics 2024 16 146 39425144 11490026
Li, W. et al. Detection of SNCA and FBN1 Methylation in the Stool as a Biomarker for Colorectal Cancer. Disease Markers 657570 (2015). (2015).
Caputo V et al. Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer Explor. Target. Antitumor Ther. 2023 4 102 138 36937316 10017193
Zhang X et al. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas World J. Gastroenterol. 2015 21 2629 2637 25759530 4351212
Vega-Benedetti AF et al. Colorectal cancer early detection in stool samples tracing CpG Islands methylation alterations affecting gene expression Int. J. Mol. Sci. 2020 21 4494 32599859 7349989
Shavali M Moradi A Tahmaseb M Mohammadian K Ganji SM Circulating-tumour DNA methylation of HAND1 gene: a promising biomarker in early detection of colorectal cancer BMC Med. Genomics 2024 17 117 38689296 11061902
Li D et al. Discovery and validation of tissue-specific DNA methylation as noninvasive diagnostic markers for colorectal cancer Clin. Epigenetics 2022 14 102 2022rcod.book...L 35974349 9382793
Ruiz-Bañobre J et al. Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA Clin. Epigenetics 2022 14 86 35810318 9271259
Gu S et al. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer Clin. Epigenetics 2019 11 41 30846004 6407227
Long L et al. Significance of SDC2 and NDRG4 methylation in stool for colorectal cancer diagnosis Clin. Biochem. 2024 124 110717 38224931
Roperch JP et al. Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer BMC Cancer 2013 13 566 24289328 4219483
Zhang W et al. SDC2 and TFPI2 methylation in stool samples as an integrated biomarker for early detection of colorectal cancer Cancer Manag Res. 2021 13 3601 3617 2021uap.book...Z 33958894 8096344
Semaan A et al. SEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomas Clin. Epigenetics 2016 8 100 27660666 5028994
Glöckner SC et al. Methylation of TFPI2 in stool DNA: A potential novel biomarker for the detection of colorectal cancer Cancer Res. 2009 69 4691 4699 19435926 3062162
Hernandez-Blazque F et al. Evaluation of global DNA hypomethylation in human colon cancer tissues by immunohistochemistry and image analysis Gut 2000 47 689 693 1728119
Rodriguez J et al. Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers Cancer Res. 2006 66 8462 9468 16951157
Feinberg AP Gehrke CW Kuo KC Ehrlich M Reduced genomic 5-methylcytosine content in human colonic neoplasia Cancer Res. 1988 48 1159 1161 3342396
Huang M et al. Crosstalk between cancer cells and the nervous system Med. Adv. 2023 1 173 189
Fortin JP Triche TJ Jr Hansen KD Preprocessing, normalization and integration of the illumina humanmethylationepic array with Minfi Bioinformatics 2017 33 558 560 28035024
Ross JP et al. Batch-effect detection, correction and characterisation in illumina HumanMethylation450 and methylationepic BeadChip array data Clin. Epigenetics 2022 14 58 35488315 9055778
Galanter JM et al. Differential methylation between ethnic sub-groups reflects the effect of genetic ancestry and environmental exposures Elife 2017 6 e20532 28044981 5207770
Chan MH Merrill SM Konwar C Kobor MS An integrative framework and recommendations for the study of DNA methylation in the context of race and ethnicity Discov Soc. Sci. Health 2023 3 9 37122633 10118232
